ScholarIQanswers from OpenAlex
Ludwig Cancer Research
InstitutionResearch output, impact & collaborations
Ludwig Cancer Research is a institution indexed in ScholarIQ from OpenAlex.
What is known about Ludwig Cancer Research?
ScholarIQrecord summary
Ludwig Cancer Research is a research organisation in Zurich, CH. OpenAlex records 3,306 works and 868,357 citations for it. 553 researchers list it as their most recent affiliation.
How many works does Ludwig Cancer Research have?
ScholarIQindexed works
Ludwig Cancer Research has 3,306 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ludwig Cancer Research have?
ScholarIQcitation count
Ludwig Cancer Research has 868,357 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Ludwig Cancer Research?
ScholarIQresearcher count
Ludwig Cancer Research has 553 researchers in the ScholarIQ index.
What is the average h-index at Ludwig Cancer Research?
ScholarIQavg h-index
Ludwig Cancer Research has an average h-index of 117.5 in OpenAlex.
What is the ROR of Ludwig Cancer Research?
ScholarIQror
The ROR for Ludwig Cancer Research is on the source record.
What is the OpenAlex record for Ludwig Cancer Research?
ScholarIQopenalex
The OpenAlex for Ludwig Cancer Research is on the source record.
Who are the most-cited researchers behind Ludwig Cancer Research?
ScholarIQtop researchers by citations
What are the most-cited papers on Ludwig Cancer Research?
ScholarIQmost cited works
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan, Jermaine Coward, Robert C. Bast, Andy Berchuck, Jonathan S. Berek, James D. Brenton, George Coukos, Christopher Crum, Ronny Drapkin, Dariush Etemadmoghadam, Michael Friedländer, Hani Gabra, Stan B. Kaye, Christopher J. Lord, Ernst Lengyel, Douglas A. Levine, Iain A. McNeish, Usha Menon, Gordon B. Mills, Kenneth P. Nephew, Amit M. Oza, Anil K. Sood, Euan A. Stronach, Henning Walczak, David D.L. Bowtell, Frances R. Balkwill
A colorectal cancer classification system that associates cellular phenotype and responses to therapy
Anguraj Sadanandam, Costas A. Lyssiotis, Krisztián Homicskó, Eric A. Collisson, William J. Gibb, Stephan Wullschleger, Liliane C Gonzalez Ostos, William A Lannon, Carsten Grötzinger, Maguy Del Rio, Benoît Lhermitte, Adam B. Olshen, Bertram Wiedenmann, Lewis C. Cantley, Joe W. Gray, Douglas Hanahan
Interrogating open issues in cancer precision medicine with patient-derived xenografts
Annette T. Byrne, Denis Alférez, Frédéric Amant, Daniela Annibali, Joaquı́n Arribas, Andrew V. Biankin, Alejandra Bruna, Eva Budínská, Carlos Caldas, David K. Chang, Robert B. Clarke, Hans Clevers, George Coukos, Virginie Dangles‐Marie, S. Gail Eckhardt, Eva González‐Suárez, Els Hermans, Manuel Hidalgo, Monika A. Jarzabek, Steven de Jong, Jos Jonkers, Kristel Kemper, Luisa Lanfrancone, Gunhild M. Mælandsmo, Elisabetta Marangoni, Jean‐Christophe Marine, Enzo Médico, Jens Henrik Norum, Héctor G. Pálmer, Daniel S. Peeper, Pier Giuseppe Pelicci, Alejandro Piris‐Giménez, Sergio Roman‐Roman, Oscar M. Rueda, Joan Seoane, Violeta Serra, Laura Soucek, Dominique Vanhecke, Alberto Villanueva, Emilie Vinolo, Andrea Bertotti, Livio Trusolino
Cancer and Inflammation: Promise for Biologic Therapy
Sandra Demaria, Eli Pikarsky, Michael Karin, Lisa M. Coussens, Yen‐Ching Chen, Emad El‐Omar, Giorgio Trinchieri, Steven M. Dubinett, Jenny T. Mao, Éva Szabó, Arthur Μ. Krieg, George J. Weiner, Bernard A. Fox, George Coukos, Ena Wang, Robert T. Abraham, Michele Carbone, Michael T. Lotze
How much of the research on Ludwig Cancer Research is open access?
ScholarIQopen access share
75%OPEN ACCESS